Por: RTTNews Health January 09, 2024
BioNTech SE () said it projects total company revenues of approximately 3 billion euros for financial year 2024, mainly driven by the COVID-19 vaccine franchise which is expected to remain profitable given the cost sharing structure with its partner Pfizer Inc. BioNTech ended 2023 with approximately 17.5 billion euros in cash, cash equivalents and security investments. The company plans to maintain a strong financial position and generate... + full article
RTTNews USA Health May 08, 2023
BioNTech SE () said its financial performance has been fully in line with the company's expectations for the first quarter of 2023. Commercial revenues decreased due to lower demand for COVID-19 vaccine. For fiscal 2023, the company continues to project BioNTech COVID-19... + más
FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews
CNBC USA Health March 27, 2023
Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022.Rodrigo Garrido ReutersShares of on Monday slid by more than 6% in morning trading after the... + más
RTTNews USA Health March 15, 2023
The U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.In a statement, the regulator said it has amended the emergency use authorization or EUA of the Pfizer-BioNTech... + más
Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica
Politico USA Health February 09, 2023
The Centers for Disease Control and Prevention added Covid-19 vaccinations for children, adolescents and adults to its immunization schedule. These updates reflect current agency recommendations. Adding them formalizes that guidance for health care providers and schools. The... + más
States, not CDC, set school vaccination requirements | Los Angeles Times
FACT FOCUS: States, not CDC, set school vaccine requirements | ABC News
The Boston Globe USA Business October 08, 2022
Pfizer and BioNTech, the duo behind the world’s most widely used COVID-19 vaccine, and one of the most successful pharmaceutical products of all time, are developing a trio of new vaccines that could spur stronger, broader, and longer-lasting immunity to the... + más
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
The Verge USA Health September 24, 2022
Moderna is suing Pfizer over its coronavirus vaccineModerna is suing Pfizer over its coronavirus vaccine / The company is filing patent infringement lawsuits against Pfizerp>span:first-child]:text-black text-blurple>By Aug 26, 2022, 12:37 PM UTC Share this story... + más
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
About iurex | Privacy Policy | Disclaimer |